Table 2 Intention-to-treat analysis, sickness absences before and after the intervention (n = 22)
Outcome variable Men | Baseline 6 months before the intervention 1.5.2015–31.10.2015 | 6 months after the intervention 1.5.2017–31.10.2017 | Main comparison between intervention and control groups (CI 95%) | |||
|---|---|---|---|---|---|---|
Control unit | Intervention unit | Control unit | Intervention unit | |||
n = 11 | n = 11 | n = 11 | n = 11 | |||
Primary outcome | mean (sd) | mean (sd) | mean (sd) | mean (sd) | ||
Medium-term SA (4–14 days) | 187 (160) | 151 (111) | 201 (176) | 149 (70) | 22 | − 46 to 91 |
Secondary outcome | ||||||
Short-term SA (1–3 days) | 316 (230) | 319 (327) | 381 (319) | 317 (195) | 66 | − 122 to 255 |
Long-term SA (15+ days) | 94 (63) | 84 (48) | 99 (65) | 81 (45) | 10 | − 23 to 43 |
Total length of SA, days | 4378 (2751) | 3886 (2396) | 4755 (3486) | 3834 (2075) | 486 | − 1118 to 2091 |
Number of SA episodes | 598 (442) | 554 (478) | 681 (552) | 547 (292) | 104 | − 177 to 384 |
Women | ||||||
Primary outcome | mean (sd) | mean (sd) | mean (sd) | mean (sd) | ||
Medium-term SA (4–14 days) | 116 (96) | 153 (156) | 160 (122) | 193 (138) | −16 | − 123 to 91 |
Secondary outcome | ||||||
Short-term SA (1–3 days) | 261 (242) | 331 (399) | 323 (243) | 357 (178) | −18 | − 201 to 165 |
Long-term SA (15+ days) | 68 (74) | 93 (85) | 89 (75) | 105 (62) | −3 | − 52 to 47 |
Total length of SA, days | 3041 (3116) | 4172 (4161) | 3978 (3405) | 4772 (2952) | − 233 | − 2655 to 2189 |
Number of SA episodes | 445 (408) | 577 (626) | 571 (429) | 655 (365) | − 41 | − 372 to 290 |